ShuYu Civilian Pharmacy Management
Management criteria checks 2/4
ShuYu Civilian Pharmacy's CEO is Guangxia Qin, appointed in Nov 2018, has a tenure of 5.5 years. directly owns 18.24% of the company’s shares, worth CN¥984.83M. The average tenure of the management team and the board of directors is 4.5 years and 2.4 years respectively.
Key information
Guangxia Qin
Chief executive officer
CN¥1.1m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 5.5yrs |
CEO ownership | 18.2% |
Management average tenure | 4.5yrs |
Board average tenure | 2.4yrs |
Recent management updates
CEO
Guangxia Qin (52 yo)
5.5yrs
Tenure
CN¥1,065,600
Compensation
Ms. Guangxia Qin serves as President and Director at ShuYu Civilian Pharmacy Corp., Ltd.
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | 5.5yrs | CN¥1.07m | 18.24% CN¥ 984.8m | |
Financial Director | 4.5yrs | CN¥396.20k | no data | |
VP & Director | 2yrs | CN¥523.90k | no data | |
VP, Board Secretary & Director | no data | CN¥1.35m | no data |
4.5yrs
Average Tenure
51yo
Average Age
Experienced Management: 301017's management team is considered experienced (4.5 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President & Director | 5.5yrs | CN¥1.07m | 18.24% CN¥ 984.8m | |
VP & Director | 2yrs | CN¥523.90k | no data | |
VP, Board Secretary & Director | 5.5yrs | CN¥1.35m | no data | |
Chairman of the Board | 5.5yrs | CN¥1.01m | 35.4% CN¥ 1.9b | |
Independent Director | 2.4yrs | CN¥60.00k | no data | |
Chairman of Supervisory Board | 2.4yrs | no data | no data | |
Non-Independent Director | 2.4yrs | no data | no data | |
Non-Independent Director | 2.4yrs | CN¥559.10k | no data | |
Independent Director | 2.4yrs | CN¥60.00k | no data | |
Independent Director | 2.4yrs | CN¥60.00k | no data | |
Employee Representative Supervisor | no data | no data | no data | |
Supervisor | 1.8yrs | no data | no data |
2.4yrs
Average Tenure
51yo
Average Age
Experienced Board: 301017's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.